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characterization of ATP synthase
complexes from mitochondria
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Graham C. Robinson, Ian M. Fearnley and John E. Walker
The Medical Research Council Mitochondrial Biology Unit, Hills Road,
Cambridge CB2 0XY, UK1. Summary
The mitochondrial F1-ATPase inhibitor protein, IF1, inhibits the hydrolytic, but
not the synthetic activity of the F-ATP synthase, and requires the hydrolysis of
ATP to form the inhibited complex. In this complex, the a-helical inhibitory
region of the bound IF1 occupies a deep cleft in one of the three catalytic inter-
faces of the enzyme. Its N-terminal region penetrates into the central aqueous
cavity of the enzyme and interacts with the g-subunit in the enzyme’s rotor.
The intricacy of forming this complex and the binding mode of the inhibitor
endow IF1 with high specificity. This property has been exploited in the devel-
opment of a highly selective affinity procedure for purifying the intact F-ATP
synthase complex from mitochondria in a single chromatographic step by
using inhibitor proteins with a C-terminal affinity tag. The inhibited complex
was recovered with residues 1–60 of bovine IF1 with a C-terminal green fluor-
escent protein followed by a His-tag, and the active enzyme with the same
inhibitor with a C-terminal glutathione-S-transferase domain. The wide appli-
cability of the procedure has been demonstrated by purifying the enzyme
complex from bovine, ovine, porcine and yeast mitochondria. The subunit com-
positions of these complexes have been characterized. The catalytic properties
of the bovine enzyme have been studied in detail. Its hydrolytic activity is sen-
sitive to inhibition by oligomycin, and the enzyme is capable of synthesizing
ATP in vesicles in which the proton-motive force is generated from light by
bacteriorhodopsin. The coupled enzyme has been compared by limited trypsi-
nolysis with uncoupled enzyme prepared by affinity chromatography. In the
uncoupled enzyme, subunits of the enzyme’s stator are degraded more rapidly
than in the coupled enzyme, indicating that uncoupling involves significant
structural changes in the stator region.2. Introduction
The F-ATP synthase, or F1Fo-ATPase, from mitochondria is an abundant multi-
subunit assembly associated with the inner membranes of the organelle [1,2].
The high-resolution structural analysis of the F-ATP synthase has been con-
ducted by the detailed analysis of constituent domains, largely by X-ray
crystallography [3–10]. These substructures have been assembled into an over-
all mosaic structure within the constraints of a 32 A˚ resolution overall structure
determined by cryo-electron microscopy of single particle images of the intact
enzyme complex [10,11]. A series of structures of the F1 catalytic domain
from both the bovine [3–7,12] and yeast [13,14] enzymes describes the structural
changes that occur in the a3b3 subdomain in response to the anticlockwise
rotation of the central stalk of the enzyme (as viewed from its membrane
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2domain), and provides a detailed description of the catalytic
mechanism of ATP hydrolysis by F1-ATPase. The structure of
the membrane extrinsic region of the enzyme was completed
by the addition of the structure of the peripheral stalk, which
demonstrated its mode of attachment to the F1 domain via an
interaction between the oligomycin sensitivity conferral
protein (OSCP) with the N-terminal region of one of the
three a-subunits [8,9,15]. The structural analysis of the mem-
brane domain of the enzyme is less advanced, but structures
have been determined for the F1–c ring complexes from
bovine [10] and yeast mitochondria [16], which contain the
complete rotors. However, as yet, there is no high-resolution
structural information describing the rest of the membrane
domain of the enzyme, and therefore a molecular description
is lacking of how the transmembrane proton-motive force is
coupled to ATP synthesis, and of how rotation is generated.
One possible approach to filling this lacuna would be to
crystallize the intact F1Fo-ATPase complex, and to determine
its high-resolution structure by X-ray crystallography.
One severe practical problem especially has impeded
this approach. As described in this study, the interface
between the c-ring and subunit a is unstable, and the removal
of phospholipids and their replacement by detergents often
uncouples the proton-motive force from ATP synthesis by
disrupting the interactions between subunit a and the
c-ring. Thus, any structural information about how they
interact is lost. To overcome this problem, as described
here, we have developed a simple, rapid and mild purifi-
cation of the F1Fo-ATPase complex from mitochondria that
takes advantage of the exquisitely specific inhibition of the
mitochondrial F1Fo-ATPase by its natural inhibitor protein,
IF1 [17]. The binding of the inhibitor to the enzyme requires
the hydrolysis of ATP, and only the ATP hydrolytic (and
not its synthetic activity) is inhibited. It has been suggested
that IF1 may also inhibit ATP synthesis [18], but this effect
has not been demonstrated directly on the isolated enzyme.
Bovine IF1 is a predominantly a-helical protein [19] that, in
the inhibited complex, is deeply buried in a channel in one
of three catalytic interfaces of the F1 catalytic domain of the
enzyme [20,21]. In the inhibited complex, the C-terminal
part of the inhibitor protein is exposed, and extends from
the surface of the F1 domain. Therefore, affinity tags have
been attached to the C-terminus of appropriately engineered
inhibitor proteins to facilitate the purification of the inhibi-
ted complex. After the inhibition of the F1Fo-ATPase, the
detergent-solubilized inhibited complex has been bound selec-
tively to an appropriate affinity column. Then, in a subsequent
step, either the inhibited F1Fo complex or the active complex
has been recovered. These enzyme preparations are free from
contaminants, and they are almost entirely fully coupled. The
versatility of the procedure is demonstrated here by the purifi-
cation of the enzyme complex from bovine, ovine, porcine and
yeast mitochondria.3. Material and methods
3.1. Analytical procedures
Protein concentrations were measured by the bicinchoninic
acid method (Pierce Biotechnology). The ATPase activity of
samples was determined by coupling it to the oxidation of
NADH monitored at 340 nm [22]. In this assay, hydrolysedATP is regenerated by a transfer of phosphate from phospho-
enolpyruvate to ADP catalysed by pyruvate kinase generating
pyruvate. Pyruvate is converted to lactate-by-lactate dehydro-
genase with concomitant oxidation of NADH to NADþ. Thus,
the rate of the decrease in absorbance at 340 nm is directly
proportional to the rate of ATP hydrolysis. The enzymes and
substrates are added in excess to ensure that the rate of
NADH oxidation is limited only by the hydrolytic activity
of the ATPase. The effect of oligomycin on this activity was
determined by addition of the inhibitor (0.1 mg ml21; w/v) in
ethanolic solution.3.2. Isolation of mitochondria and mitochondrial
membranes
Mitochondria were isolated from bovine, ovine and porcine
hearts, as described previously for bovine mitochondria
[23], and stored at 2208C. Mitochondria were prepared
from 55 l cultures of Saccharomyces cerevisiae (W303–1A,
Mat a, ade2-1, trp1-1, leu2-3,112, ura3-1, his3-11,15, ybp1-1
plus a canavanine-resistance marker) grown at 308C in a
medium consisting of peptone (20 g l21), yeast extract
(10 g l21), 3 per cent glycerol (v : v), adenine (0.05 g l21) and
antifoam 204 (180 ml l21; Sigma-Aldrich) in an Applikon
ADI1075 fermentor (Applikon Biotechnology). At the end
of logarithmic growth when the OD600 had reached 8–9,
the cells were cooled to 208C, harvested by continuous
centrifugation at 18 000g, broken by passage through a dyno-
mill disruptor (WA Bachofen AG), and centrifuged for
20 min at 4800g and then for 10 min at 4200g. Themitochondria
were obtained from the supernatant by centrifugation (32 000g,
50 min). They were washed twice in a buffer containing
100 mM Tris–HCl, pH 7.5, 650 mM sorbitol, 5 mM aminohex-
anoic acid, 5 mMbenzamidine and 0.005 per cent PMSF (w/v),
and stored at2208C, at a protein concentration of 10 mg ml21,
in suspension in a buffer consisting of 20 mM Tris–HCl, pH
8.0, containing 10 per cent glycerol (v/v). The yield of
mitochondrial protein from a 55 l culture was 6–8 g.
Ammonium sulphate (AS) particles were prepared from
bovine mitochondria, as described previously [24].3.3. Over-expression and purification of
inhibitor proteins
Sequences encoding residues 1–60 of bovine IF1 plus
C-terminal hexahistidine, and with C-terminal glutathione-
S-transferase (GST), or green fluorescent protein (GFP), plus
hexahistidine, and of residues 14–60 of bovine IF1 with
C-terminal GST plus hexahistidine, were all cloned individu-
ally into the expression plasmid pRun [25]. The proteins were
expressed in Escherichia coli C41 (DE3), and purified by affi-
nity chromatography on a Hi-Trap nickel sepharose column
(5 ml; GE Healthcare), as described previously [26]. Pooled
fractions containing inhibitor proteins were dialysed for 4 h
against 2 l of buffer consisting of 20 mM Tris–HCl, pH 7.4,
and concentrated to 10 mg ml21 with a VivaSpin concentra-
tor (molecular weight cut-off 5 kDa; Sartorius). The yields
of inhibitor proteins referred to as I1–60His, I1–60GFPHis
and I1–60GSTHis were 10, 100 and 100 mg l21, respectively.
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33.4. Purification of inhibited F1Fo-ATPase complexes
Bovine heart (and ovine and porcine heart) mitochondrial
membranes were suspended in phosphate buffer consisting
of 50 mM disodium hydrogen orthophosphate, pH 9.2,
100 mM sucrose and 0.5 mM EDTA, and then centrifuged
(13 700g, 30 min, 48C). This procedure, which was repeated
twice, removed endogenous IF1 bound to the bovine
ATPase, but it was not applied to mitochondria from
S. cerevisiae as they have low amounts of bound endogenous
IF1. The pellet of phosphate-washed animal mitochondria (or
unwashed yeast mitochondria) was re-suspended at a protein
concentration of 8.5 or 10 mg ml21, respectively, in a buffer
containing 20 mM Tris–HCl, pH 8.0, and 10 per cent glycerol
(v/v). To 50 ml portions of this suspension, 5.5 ml of a sol-
ution of 10 per cent (w/v) dodecylmaltoside (DDM) was
added to a give a final detergent concentration of 1 per cent
(w/v). The suspensions were kept at room temperature for
10 min, and then centrifuged (24 000g, 10 min). In a typical
experiment, the ATPase activity in a DDM extract of bovine
mitochondrial membranes (382 mg of protein) was inhibited
with I1–60His (1.0 mg), and 750 ml of a solution containing
200 mM ATP, 200 mM MgCl2 and 400 mM Trizma base was
added. The sample was incubated at 378C for 15 min, and
further portions (750 ml) of the ATP solution were added
every 5 min. After centrifugation (10 000g, 10 min), sodium
chloride (0.3 g) and 5 M neutralized imidazole were added
to the supernatant to final concentrations of 0.1 M and
25 mM, respectively. This solution was applied at a flow
rate of 1 ml min21 to a nickel Sepharose HisTrap HP
column (5 ml; GE Healthcare) equilibrated in buffer B
(20 mM Tris–HCl, pH 7.4, 10% (v/v) glycerol, 0.1% (w/v)
DDM, 1 mMATP, 2 mMMgSO4, 0.1 M NaCl and 25 mM imi-
dazole). The F1Fo–I1–60His inhibited complex was eluted
with a linear imidazole gradient of 25–500 mM over
100 ml. The recovery of the inhibited complex was 25 mg.
This procedure was performed at 238C.
3.5. Purification of active F1Fo-ATPase
Active bovine F1Fo-ATPase was purified in a similar way to
the inhibited complex, except that the ATPase activity of
the DDM extract (50 ml) was inhibited with 2.9 mg of I1–
60GSTHis. The F1Fo-I1–60GSTHis complex was applied to
two GSTrap HP columns (each 5 ml; GE Healthcare) con-
nected in series, equilibrated in buffer C consisting of
20 mM Tris–HCl, pH 7.3, 0.1 per cent DDM, 10 per cent gly-
cerol, 0.15 M NaCl and 5 mM dithiothreitol. The bound
protein was washed with buffer D containing 20 mM Tris–
HCl pH 7.3, 0.1 per cent DDM, 10 per cent glycerol and
10 mM EDTA at a flow rate of 1 ml min21. When the conduc-
tivity of the eluate had reached a stable baseline, the flow of
buffer was stopped for 17 h. Then, the active F1Fo-ATPase
complex was recovered at a buffer flow rate of 0.5 ml min21.
The preparation of the active bovine complex was
repeated with various phospholipids (final concentration
of 0.1 mg ml21) in the chromatography buffers. The
phospholipids were asolectin (a mixture of phopholipids
from soya beans; Sigma-Aldrich), and the following
mixtures (Avanti Polar lipids): bovine cardiolipin (CL) :
bovine phosphatidylcholine (PC) : bovine phosphatidyl-
ethanolamine (PE) (3 : 1 : 1, by wt); asolectin : bovine CL
(1 : 3, by wt); bovine heart polar phospholipid extract(BHPPE); and 1-palmitoyl-2-oleoyl-sn-glycero-3-[phospha-
rac-(1-glycerol)] (POPG) : 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphoethanolamine (POPE) : 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC) (3 : 1 : 1, by wt).
3.6. Partial trypsinolysis of F1Fo-ATPase
Trypsin (3.5 ml; 1 mg ml21 in 1 mM hydrochloric acid) was
added to a sample of bovine F1Fo-ATPase (350 ml,
2 mg ml21) in 20 mM Tris–HCl, pH 7.4, containing DDM
(0.3%; w/v) to give a trypsin : F1Fo-ATPase ratio of 1 : 200
(w/w). Samples (50 ml) were removed at various intervals
up to 360 min, and proteolysis was terminated by addition
of a fivefold excess (w/w) of bovine pancreatic trypsin
inhibitor (5 mg ml21 in water).
3.7. Protein analysis
Samples of mitochondria, mitochondrial membranes, puri-
fied F1Fo-ATPases and products of partial trypsinolysis
of bovine F1Fo-ATPase were analysed by SDS–PAGE in
10–15 per cent acrylamide gradient gels, and the proteins
were detected with Coomassie blue dye. Proteins in stained
bands were identified by mass mapping of tryptic peptides
[27]. Partial proteolysis products of coupled and uncoupled
samples of bovine F1Fo-ATPase were precipitated with etha-
nol, the subunits of F1Fo-ATPases and the products of
partial proteolysis of bovine F1Fo-ATPase were separated by
RP-HPLC and their intact protein masses were measured
‘online’ to the column with a Quatro Ultima triple quadru-
pole mass spectrometer with electrospray ionization
(Micromass), as described previously [28].
3.8. Preparation of liposomes
Chicken egg phosphatidylcholine and E. coli polar lipid
extract dissolved in chloroform were mixed in a ratio of
1 : 3 (w : w). The lipid composition was chosen in order to
maximize coupling in the liposomes. The particular phospho-
lipid mixture does not compare with the lipids present in the
mitochondrial membrane but has been used extensively
before in reconstitution studies [29]. The solvent was evapor-
ated in a stream of nitrogen, and the dried phospholipids
were re-dissolved in an equivalent volume of water. Unilamel-
lar liposomes of uniform sizewere prepared bya passage of the
solution five times through a polycarbonate filter (0.1 mm pore
size; Millipore Corporation). They were stored at 48C at a phos-
pholipid concentration of 20 mg ml21 in a buffer containing
20 mM MOPS, pH 7.4 and 50 mM KCl.
3.9. Reconstitution of F1Fo-ATPase into liposomes
Liposomes (400 ml) were de-stabilized in the presence
of samples of purified bovine F1Fo-ATPase (70 ml,
10 mg ml21) by addition of Triton X-100. F1Fo-ATPase was
purified in the absence of any phospholipids. The requisite
amount of Triton X-100 was calculated from the absorption
of the vesicles at 600 nm following addition of 400 ml of phos-
pholipid vesicles to 10 ml quantities up to 50 ml of 10 per cent
(w/v) Triton X-100. The volume of the mixture was adjusted
to 2.4 ml with 20 mM Tris–HCl, pH 7.4. The detergent was
removed by the gradual addition of Biobeads (Biorad Labora-
tories) up to 10 mg mg21 of detergent and then over 12 h up
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Figure 1. Purification of the F1Fo-ATPase inhibitor complexes from bovine, ovine, porcine and yeast mitochondria by nickel affinity chromatography. The inhibitor
was (a,b) I1–60GFPHis and (c) I1–60His. (a) Elution profile of the inhibited bovine F1Fo-ATPase-I1–60GFPHis complex monitored at 280 nm. (b) SDS–PAGE
analysis of fraction 43 (1 ml) from (a). The inhibitor protein is found between the g- and b-subunits (compare with (c)). (c) Tracks 1–4 are purified inhibited
F1Fo-ATPase-I1–60His from cows, sheep, pigs and S. cerevisiae, respectively. Subunits were identified by mass spectrometric analysis of peptides derived from stained
bands.
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4to a total of 20 mg of Biobeads per mg of detergent. The pro-
teoliposomes were centrifuged (60 000g, 45 min) and then re-
suspended in buffer (250 ml) containing 20 mM Tris–HCl,
pH 7.4.3.10. Proton pumping coupled to ATP hydrolysis in
proteoliposomes
A portion of proteoliposomes (10 ml) were added to a
solution containing 20 mM MOPS, 20 mM KCl and 0.5 mM
valinomycin to give a final volume of 1 ml. 9-amino-6-
chloro-2-methoxyacridine (ACMA) was added to a final
concentration of 1 mM. The proton-pumping activity of the
F1Fo-ATPase was initiated by the addition of ATP to a final
concentration of 100 mM, and terminated by the addition of
either I1–60GFP or oligomycin, to final concentrations of
0.5 or 0.665 mM, respectively. The change in fluorescence at
excitation and emission wavelengths of 430 and 475 nm,
respectively, was measured in a Shimaduzu RF-5301 PC
dual wavelength spectrophotometer. ACMA binds to mem-
branes in the energized state and becomes quenched when
a pH gradient is established.3.11. ATP synthesis in proteoliposomes
Purple membranes were purified from Halobacterium halobium
as described before [30], and bacteriorhodopsin was solubil-
ized in 2 per cent (v/v) Triton X-100. Proteoliposomes
containing both F1Fo-ATPase and bacteriorhodopsin were
prepared as described earlier, except that solubilized bacter-
iorhodpsin (300 ml; 2 mg ml21) was added also to the
reconstitution mixture. A portion of the resulting proteolipo-
somes (10 ml) was suspended in a solution containing 20 mM
Tris–HCl, pH 7.4, 200 mM phosphate and 200 mM ADP. The
stirred suspension (750 ml) was illuminated with a halogen
bulb. Samples (75 ml) were removed at various times and
quenched with 75 ml of aqueous trichloroacetic acid
(40 g l21). The ATP content was estimated by luciferin–luci-
ferase assay with an ATP Bioluminescence kit (Roche).4. Results
4.1. Purification of inhibited and active F1Fo-ATPase
The F1Fo-ATPase inhibitor complex was purified from mito-
chondria from cows, sheep, pigs and S. cerevisiae (figure 1).
The average yields of the purified complexes from about
380 mg of total protein in phosphate-washed mitochondria
were 25, 10 and 16 mg for the bovine, porcine and ovine com-
plexes, respectively. The yield of the inhibited complex from
S. cerevisiaemitochondriawas15 mg g21ofmitochondrialprotein.
The inhibition of mitochondrial F1-ATPase by IF1 has been
reported to be reversed by a range of reagents [31–33]. They
include oxyanions such as sulphate, sulphite, bicarbonate,
borate, phosphate and pyrophosphate, and the chelating agent
EDTA. In an initial survey conducted in solution, each of them
was investigated, at various concentrations and under a variety
of conditions, as agents for releasingF1Fo-ATPase from the inhib-
ited bovine complex. From these investigations, EDTA was
identified as the reagent that released the highest activity of
F1Fo-ATPase. It probably acts by removal of magnesium ions
associatedwith nucleotides bound in the catalytic and non-cata-
lytic sites of the enzyme, resulting in the destabilization of the
interaction with the inhibitor protein. However, EDTA could
not be used for releasing the active enzyme from the inhibited
complex bound to a nickel–NTA column via the histidine tag
of the inhibitor protein, although borate was used successfully
to release the active enzyme (data not shown). Therefore, the
inhibited complexwas bound to a column of immobilized gluta-
thione via the GST domain of I1–60GSTHis, and then the active
enzyme was released with EDTA (figure 2). The recovery of
active bovine F1Fo-ATPase from about 380 mg of protein in
the DDM extract of mitochondria was 11 mg, with a specific
activity of 4.0 mmolmin21mg21.
4.2. Subunit compositions of purified
F1Fo-ATPase complexes
The subunit compositions of the various purified complexes
were analysed by SDS–PAGE, and by mass-mapping the
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Figure 2. Purification of active bovine F1Fo-ATPase by GST affinity chromato-
graphy. (a) SDS–PAGE analysis of fractions 4–13 (each 1 ml) recovered from
the column after reversal of inhibition with EDTA. (b) Analysis of pooled frac-
tions of purified bovine F1Fo-ATPase. Subunits were identified by mass
mapping of tryptic peptides derived from stained bands.
Table 1. Effect of phospholipids on the activity of bovine F1Fo-ATPase. The phospholipids were added to buffers used in the purification of the active enzyme
(see §3).
preparation additives
specific activity
(mmol min21 mg21)
oligomycin sensitivity
(% inhibition)
AS particles none 30.0+ 3.7a 91.0+ 1.5
DDM extract none 27.6+ 4.0a 83.8+ 4.7
F1Fo-ATPase none 4.4+ 1.3 8.6+ 3.1
F1Fo-ATPase asolectin 50 40
F1Fo-ATPase CL : PC : PE
b 22.2+ 4.8 77.2+ 3.6
F1Fo-ATPase asolectin : CL
c 49 75
F1Fo-ATPase BHPPE 16 66
F1Fo-ATPase POPC : POPG : POPE
d 21.1+ 3.5 90.0+ 1.6
F1Fo-ATPase PL vesicles
e 24.7 83
a10% of the membrane protein was assumed to be F1Fo-ATPase.
b3 : 1 : 1, by wt.
c1 : 3 w/w.
d3 : 1 : 1, by wt.
ePhospholipid (PL) vesicles are composed of chicken egg phosphatidylcholine and E. coli polar lipid (1 : 3, w/w).
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5tryptic digests of the bands from the stained gels (figures 1
and 2; electronic supplementary material, tables S1 and S2).
These analyses demonstrated that the known complement
of subunits of the enzyme was present in the purified
bovine-, sheep- and pig-inhibited complexes, and in the
active bovine complex, except for the membrane subunits
DAPIT and 6.8 kDa proteolipid [34]. It is known that these
two subunits are retained in the complex only when the
enzymes are purified with phospholipids in the buffers
throughout the preparation. The yeast genome does not
encode subunits that are equivalent to DAPIT and the
6.8 kDa proteolipid, and the purified yeast enzyme also
lacked the known subunits e, g and k, which, although
they were retained when a Triton X-100 extract of mitochon-
dria from S. cerevisiae was fractionated by anion exchangechromatography [35], are weakly associated with the com-
plex. The separation of the subunits of the enzymes from
all four species by liquid chromatography (LC), coupled to
measurement of their intact masses by mass spectrometry,
confirmed their subunit compositions, and also confirmed
the presence of the hydrophobic subunits a and c, which con-
tain few tryptic cleavage sites and so are not readily
identifiable by mass mapping of tryptic peptides (see the
electronic supplementary material, table S1).
4.3. Oligomycin sensitivity of purified F1Fo-ATPase
Oligomycin inhibits ATP hydrolysis and synthesis, and is
thought to bind at the interface between the c-ring and subunit
a, and prevent rotation [36,37]. The sensitivity of ATP hydroly-
sis by the enzyme to oligomycin indicates the extent to which
ATP hydrolysis is coupled to proton translocation through the
membrane domain. When active bovine F1Fo-ATPase was pur-
ified in the presence of detergent (DDM) only, the sensitivity of
ATP hydrolysis to oligomycin was severely reduced (table 1).
This loss of oligomycin sensitivity was decreased to a greater
or lesser extent by the incorporation of various phospholipids
into the buffers used during affinity purification. The most
effective was a mixture of synthetic analogues of PE, PC and
PG, with 90 per cent of the hydrolytic activity being sensitive
to the inhibitor, and a mixture of CL, PC and PE was almost
equally effective (table 1). It should be noted that the inner
mitochondrial membrane comprises about 40–50 per cent PC
and PE, and approximately 15 per cent cardiolipin [38,39].
However, a greater percentage of cardiolipin was required in
order to achieve a high level of oligomycin sensitivity in the
purified enzyme (table 1).
In addition, enzyme prepared in the complete absence
of phospholipids has a large increase in oligomycin sensi-
tivity and ATP hydrolysis activity upon reconstitution into
phospholipid vesicles (table 1). Therefore, any decrease in
coupling and enzyme activity arising from removal of lipid
is not completely irreversible.
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Figure 3. A comparison of the degradation of uncoupled and coupled
samples of bovine F1Fo-ATPase by mild proteolysis. The uncoupled and
coupled samples correspond to samples of the enzyme purified in the
absence of phospholipids and in the presence of synthetic phospholipids,
respectively (table 1). Samples were removed after various times (given in
minutes across the top of the gel), and the products were analysed by
SDS–PAGE. The migration positions of the subunits of the enzyme complex
are indicated on the right-hand side of the gel. BPTI is the bovine pancreatic
trypisin inhibitor protein used to terminate proteolysis.
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Figure 4. A comparison of the susceptibility to trypsinolysis of the peripheral
stalk and Fo-subunits of bovine F1Fo-ATPase in samples of the uncoupled and
coupled enzymes. Samples were analysed by liquid chromatography linked
online to mass spectrometry (LC–MS) at various times during a 2 h
period of proteolysis. The histograms show the times at which the various
subunits, shown on the abscissa, were last observed. Uncoupled and coupled
samples of F1Fo-ATPase are shown in black and light grey, respectively.
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64.4. Comparison of uncoupled and coupled F1Fo-ATPase
by limited proteolysis
Structural differences between uncoupled and coupled prep-
arations of active bovine F1Fo-ATPase were probed by limited
proteolysis with trypsin. Coupled enzyme (oligomycin sensi-
tivity of 90%) was prepared in the presence of phospholipids
(POPC : POPG : POPE, 3 : 1 : 1, by wt), whereas uncoupled
enzyme (oligomycin sensitivity of 6%) was prepared in the
absence of phospholipids. In these experiments, their pat-
terns of degradation resulting from mild exposure to
trypsin over a period of 3 h were compared. Analysis of the
products of degradation by SDS–PAGE (figure 3) demon-
strated that the peripheral stalk subunits b, d and F6 were
degraded in the uncoupled enzyme, whereas they were
resistant to trypsinolysis in the coupled enzyme. The sub-
units of the F1 domain and the OSCP component of the
peripheral stalk, which interacts directly with the F1
domain, were resistant to proteolysis in both samples.
Subunit c also resisted proteolysis, but this observation is
unsurprising as the C-terminal a-helices of the subunit,
which form the external exposed surface of the assembled
c-ring, contain few trypsin cleavage sites. In both samples,
the small membrane subunits, e, f, g and A6L, were obscured
in the gel by the bovine pancreatic trypsin inhibitor, and
the Fo component subunit a, which stains poorly with the
Coomassie blue dye, was difficult to discern. Therefore,
in order to be able to examine the effect of proteolysis
more comprehensively, samples of proteolysis products
taken at the various time-points were separated by LC and
analysed by mass spectrometry (see the electronic sup-
plementary material, figures S1–S4). In the electronic
supplementary material, tables S3 and S4, the results of
these analyses are presented as a summary of when the
intact subunits in the uncoupled and coupled enzymes
were last observed during the 3 h period of proteolysis,
when the various specific fragments resulting fromproteolysis were first detected and when they were last
observed. The data for the first 2 h of degradation of the
intact peripheral stalk and Fo subunits from uncoupled
and coupled enzymes are compared in figure 4. Figure 4 con-
firms that the peripheral stalk subunits b, d and F6 are more
susceptible to proteolysis in the uncoupled enzyme than
in the coupled enzyme, and a similar trend was found with
the Fo subunits, a, g and A6L. The Fo subunits e and f were
degraded rapidly in both samples, and the intact proteins
were not detected after 10 min of proteolysis, implying
that they are similarly exposed in both the coupled and
uncoupled preparations. Figure 4 also confirms that the
OSCP subunit is resistant to proteolysis.4.5. Proton-pumping and ATP synthesis activities of
bovine F1Fo-ATPase
In order to demonstrate that the ATP hydrolase activity of the
purified bovine F1Fo-ATPase was coupled to proton pump-
ing, the enzyme purified in the presence of phospholipids
(POPC : POPG : POPE, 3 : 1 : 1, by wt) was reconstituted into
phospholipid vesicles. The presence of a proton-motive
force generated by ATP hydrolysis was demonstrated with
the fluorescent probe, ACMA (figure 5). The proton-pumping
activity was inhibited by IF1 and by oligomycin, inhibitors of
the F1 and Fo domains of the enzyme, respectively.
The purified bovine F1Fo-ATPase was also capable of
synthesizing ATP. This property was demonstrated with
phospholipid vesicles into which the F1Fo-ATPase and bacter-
iorhodopsin had been co-reconstituted. On illumination with
white light, ATP was synthesized in a linear manner, but only
in the presence of IF1 to prevent ATP hydrolysis by the small
amount of uncoupled enzyme that was present in the prep-
aration (figure 6). In the absence of white light, or in the
presence of an uncoupler, only traces of ATP were detected.
The ATP hydrolysis activity for reconstituted enzyme were
25 and 24.7 mmol min21 mg21 for enzyme purified in the
presence and absence of phospholipids, respectively.
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Figure 5. Proton-pumping activity of affinity-purified F1Fo-ATPase reconsti-
tuted into liposomes. The purified enzyme had an ATP hydrolase activity
of 24.8 mmol min21 mg21, which was 91% sensitive to oligomycin. The
formation of a proton-motive force dependent on ATP hydrolysis was mon-
itored from the change of fluorescence of ACMA. The enzyme was inhibited
with (a) oligomycin and (b) the ATPase inhibitor protein, I1–60GFP.
5 10 15 200
1000
2000
3000
4000
m
o
le
s o
f A
TP
 p
er
 m
ol
e 
of
 F
1F
o
-
A
TP
as
e
time (min)
Figure 6. The synthesis of ATP in proteoliposomes containing bovine F1Fo-
ATPase and bacteriorhodopsin. The enzyme was purified in the presence of
phospholipids (POPC : POPG : POPE, 3 : 1 : 1, by wt) and had a specific activity
of 19.3 mmol min21 mg21 that was 92% sensitive to oligomycin. The assay
was carried out in the presence of I1–60GFP to inhibit any uncoupled
enzyme. Open circles, in the presence of white light: open triangles, in
the presence of red light; open squares, in the presence of white light
plus FCCP; filled circles, control in the absence of white light and I1–60GFP.
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75. Discussion
The affinity purification of F1Fo-ATPases from mitochondria
using the high selectivity of bovine inhibitor protein IF1 is a
rapid and versatile procedure. As demonstrated here, it pro-
vides a ready means of purifying the inhibited and the
active enzyme, on a scale compatible with structural analysis,
from bovine, ovine, porcine and yeast mitochondria. Given
the high conservation of the sequences of IF1 in vertebrates,
and of the a- and b-subunits with which they interact in
the F1 domain of the enzyme [40], it is likely that the pro-
cedure has a wide applicability for purifying vertebrate
F-ATPases. Although the F1 sequences are also highly con-
served in fungi, the sequences of their IF1 proteins are rather
less well conserved; yet the bovine IF1 provides the means of
purifying the yeast F1Fo-ATPase, and the procedure works
well with other fungi also (T. J. Charlesworth, I. M. Fearnley,
J. V. Bason, M. J. Runswick and J. E. Walker 2013, unpublished
data). Thus, themethod appears to have general applicability in
many multi-cellular and unicellular eukaryotes. A few excep-
tions have arisen among the invertebrates, but in these cases
the use of mutated forms of bovine IF1 or the endogenous IF1
provides variant avenues that can be explored.
In terms of their chemical purity, as judged by SDS–
PAGE analysis and mass spectrometric analysis, the currentpreparations of the inhibited complex, captured by nickel affi-
nity chromatography using the His-tag at the C-terminus of
the I1–60GSTHis, at least equal the purity of earlier prep-
arations purified by a combination of ion exchange and gel
filtration chromatography [41]. In both cases, traces of impu-
rities still persist. By contrast, in the most pure active enzyme
preparation, where the inhibited complex was captured on a
column of immobilized glutathione via the GST domain of
the I1–60GSTHis inhibitor, these trace impurities were essen-
tially absent. However, the earlier preparation and the
present preparation made in the presence of phospholipids
differ most strikingly in their ATP hydrolase activity, and
in the coupling of ATP hydrolysis to proton pumping as
indicated by the degree of sensitivity of the ATP hydrolase
activity to inhibition by oligomycin. The sensitivity of
the activity to oligomycin of enzyme that had been affinity-
purified in the presence of synthetic phospholipids is
comparable with that of the enzyme in vesicles made from
the inner membranes of mitochondria (table 1). This same
affinity-purified preparation reconstituted into liposomes
generated a proton-motive force driven by ATP hydrolysis,
and made ATP in the presence of a proton-motive force gen-
erated independently by bacteriorhodopsin. This latter
experiment could only be made to work by inhibiting the
ATP hydrolase activity of the remaining low levels of
uncoupled enzyme with the inhibitor protein. The ATP
synthesis activity of the reconstituted enzyme (purified in
the presence of phospholipids) is 0.36 mmol min21 mg21,
approximately 70 times lower than the specific activity of
25 mmol min21 mg21 of ATP hydrolysis by the same reconsti-
tuted enzyme. Hence, traces of uncoupled enzyme will mask
any synthesis of ATP driven by the proton-motive force.
The same demonstration of ATP synthesis by the bovine
F1Fo-ATPase co-reconstituted with light-driven bacterio-
rhodopsin to generate the proton-motive force was
influential in establishing Mitchell’s chemiosmotic hypothesis
[42]. This experiment could only have succeeded with an
enzyme preparation that was completely coupled. It should
be noted that the enzyme in mitochondrial membranes at
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8the start of the purification has an ATPase activity that is not
100 per cent sensitive to oligomycin (table 1). Therefore, it is
possible that a quantity of uncoupled F1Fo-ATPase exists in
mitochondrial membranes.
The molecular basis of uncoupling of proton-motive force
and hydrolysis of ATP by F1Fo-ATPases has been little dis-
cussed and investigated previously. In the 1960s, Kagawa &
Racker demonstrated that both the OSCP and F6 were
required for reconstituting bovine F1-ATPase with Fo to
form a coupled F-ATPase complex [43,44]. In the 1990s, it
was realized from other reconstitution experiments [45–47]
that the OSCP and F6 together with subunits b and d form
a separate substructure of the F-ATPase from the central
stalk subunits g, d and 1. From these observations, the con-
cept emerged of the stator, where the peripheral stalk
(subunits b, d, OSCP and F6) links the external surface of
the F1 domain to the a subunit in the Fo domain, distinguish-
ing them functionally from the rotor (consisting of the central
stalk attached to the c-ring). The limited proteolysis exper-
iments described here add to the molecular understanding
of coupling and uncoupling. They illustrate that the struc-
tures of parts of the stator domains differ significantly in
the uncoupled and coupled F1Fo-ATPase. Uncoupling is
accompanied by an increased susceptibility to proteolysis in
parts of this structure. Presumably, this effect reflects a
change in structure involving the region of contact between
the c-ring and subunit a that provides an essential link inthe transmembrane proton translocation pathway in the
coupled enzyme. It is apparent from current structures of
the intact bovine enzyme at 18 A˚ resolution determined by
electron cryomicroscopy [48] that this region of contact is
not extensive, but an intact stator is required to maintain
the integrity of the transmembrane proton pathway. Increas-
ingly, it is becoming evident that the integrity of this
pathway depends upon the presence of bound phospholipids,
and especially cardiolipin [10]. Prolonged exposure of the
enzyme to detergents, or short-term exposure to relatively
high concentrations of many detergents, displaces the bound
phospholipids and appears to change the structure of the
stator, disrupting the proton pathway and rendering
the enzyme uncoupled. In the present rapid-affinity chromato-
graphy conducted in the presence of exogenous phospholipids,
loss of bound phospholipids is avoided, and the coupling of
the enzyme is retained. In future studies, it will be essential
to define the bound phospholipids and to understand their
roles in maintaining the coupled interface.6. Acknowledgements
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